高危PCI中计划性与备用性V-A ECMO策略比较:一项回顾性队列研究
该单中心回顾性观察研究纳入2019至2025年间74例择期高危PCI患者,比较计划性V-A ECMO(n=43)与备用策略(n=31)的院内结局。备用策略组院内MACCE发生率显著高于计划策略组(48.4% vs. 14.0%,p=0.002),多变量分析中备用策略与院内MACCE风险升高相关(校正OR 4.20,95%CI 1.35–13.10,p=0.013)。
要点
- 备用策略组院内MACCE发生率为48.4%,计划策略组为14.0%,差异有统计学意义(p=0.002)。
- 备用策略组ICU停留时间(8[5–12] vs. 6[4–9]天,p=0.03)和住院时间(15[11–20] vs. 12[9–16]天,p=0.02)均长于计划策略组。
- 多变量分析中备用策略与院内MACCE风险升高相关(校正OR 4.20,95%CI 1.35–13.10,p=0.013)。
核心结论
- 在择期高危PCI患者中,计划性V-A ECMO策略与较低的院内MACCE发生率相关,但鉴于非随机分组、纳入最终未需ECMO的备用组患者及事件数有限,该发现属假设生成性,不能确立计划性ECMO的因果获益或补救性启动的因果危害。
研究设计与样本
- 单中心回顾性观察研究,纳入2019至2025年间74例接受高危PCI并按术前确定的V-A ECMO策略管理的连续患者,计划策略组n=43(PCI前启动V-A ECMO),备用策略组n=31(预先准备ECMO设备与血管通路,仅在术中出现预定义血流动力学恶化时启动ECMO)。
- 主要终点为院内主要不良心脑血管事件(MACCE),定义为死亡、心肌梗死、卒中和再次血运重建的复合终点。
主要发现
- 两组基线变量无统计学显著差异。
- 备用策略组中19/32(61.3%)的患者在PCI期间需要ECMO支持。
- 院内MACCE发生率备用策略组为48.4%,计划策略组为14.0%,差异有统计学意义(p=0.002)。
- 备用策略组ICU停留时间(8[5–12] vs. 6[4–9]天,p=0.03)和住院时间(15[11–20] vs. 12[9–16]天,p=0.02)均长于计划策略组,血管活性-正性肌力评分也更高(p=0.033)。
- 多变量分析中,校正后备用策略与院内MACCE风险升高相关(校正OR 4.20,95%CI 1.35–13.10,p=0.013)。
局限性
- 非随机化治疗分配。
- 纳入最终未需要ECMO的备用组患者。
- 事件数有限。
- 上述发现属假设生成性,不能确立计划性ECMO的因果获益或补救性启动的因果危害。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
ABSTRACT Background The role of mechanical circulatory support (MCS) in high-risk percutaneous coronary intervention (HR-PCI) remains controversial, and the optimal timing of its initiation is not well defined. Veno-arterial extracorporeal membrane oxygenation (V-A ECMO) provides full hemodynamic support; however, comparative data on planned versus standby strategies are limited. Aim To compare clinical outcomes of planned versus standby V-A ECMO support in patients undergoing elective HR-PCI, with a focus on the impact of timing of ECMO initiation. Methods This single-center retrospective observational study included 74 consecutive patients who underwent high-risk PCI between 2019 and 2025 and were managed according to a preprocedurally determined V-A ECMO strategy. Before PCI, the multidisciplinary Heart Team selected either a planned strategy (n = 43), in which V-A ECMO was initiated before PCI, or a standby strategy (n = 31), in which ECMO equipment and vascular access were prepared in advance, but ECMO was initiated only in response to predefined intraprocedural hemodynamic deterioration. The primary endpoint was in-hospital major adverse cardiac and cerebrovascular events (MACCE), defined as a composite of death, myocardial infarction, stroke, and repeat revascularization. Results No statistically significant differences were observed in the measured baseline variables. ECMO support during PCI was required in 19/32 (61.3%) of patients in the standby-strategy group. The incidence of in-hospital MACCE was significantly higher in the standby-strategy group compared with the planned-strategy group (48.4% vs. 14.0%, p = 0.002). The standby-strategy group also had longer ICU stay (8 [5–12] vs. 6 [4–9] days, p = 0.03) and hospital stay (15 [11–20] vs. 12 [9–16] days, p = 0.02), as well as higher vasoactive-inotropic scores (p = 0.033). In multivariable analysis, the standby strategy was associated with higher odds of in-hospital MACCE after adjustment (adjusted OR, 4.20; 95% CI, 1.35–13.10; p = 0.013). Conclusions In this single-center retrospective cohort of patients undergoing elective HR-PCI, a planned V-A ECMO strategy was associated with a lower incidence of in-hospital MACCE than a standby strategy. Given the nonrandomized treatment allocation, inclusion of standby patients who did not ultimately require ECMO, and limited number of events, these findings are hypothesis-generating and do not establish a causal benefit of planned ECMO or harm from rescue initiation.
引用
- Catheterization and Cardiovascular Interventions:Planned Versus Standby V‐A ECMO Strategy During High‐Risk PCI: A Retrospective Cohort Study
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。